Publications

Hogan Lovells Publications

Podcast series: False Claims Act 2019 and the road ahead Hogan Lovells

In addition to the False Claims Act Guide: 2019 and the road ahead, we are featuring a six-part podcast series based on select sections of the report. Go behind-the-scenes for more in-depth ...

Analysis

Germany - Patent infringement: What to consider when applying for a preliminary injunction
Registered Content

Enforcing patents in preliminary injunction (PI) proceedings in Germany can be a very powerful and efficient means of enforcing patent rights in Germany. In practice they are often the only ...

Insights

Germany is going to specify safety expectations for reimbursable digital health applications
Registered Content

Last month, Germany introduced the Digital Health Service Act, which grants German patients access to reimbursable digital health applications.In order to establish the procedural...

Hogan Lovells Publications

Podcast: Talking the cure

Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting edge topics such as...

Insights

Federal Circuit Acetris decision changes procurement country of origin landscape
Registered Content

On Monday, in the much-anticipated decision in Acetris Health, LLC v. U.S. 18-2399, the Court of Appeals for the Federal Circuit (the “Federal Circuit”) ruled that U.S....

Insights

OIG clears manufacturer-sponsored travel and lodging support in limited circumstances
Registered Content

The latest advisory opinion published by the U.S. Department of Health and Human Services Office of the Inspector General (HHS OIG) approves one pharmaceutical manufacturer’s travel...

Insights

“Misleading” to suggest a biosimilar is inferior, FDA draft guidance warns
Registered Content

As part of its continuing efforts to advance biologics competition, the U.S. Food and Drug Administration (FDA) on February 3 published a 10-page Q&A draft guidance, “Promotional...

Analysis

CJEU clarifies assessment under competition law of pay-for-delay deals in the pharmaceutical sector
Registered Content

On 30 January 2020, the Court of Justice of the European Union (CJEU) issued its decision on a request for preliminary ruling submitted by the UK Competition Appeal Tribunal (CAT) in a case ...

Insights

CMS’ 2021 health insurance exchanges proposal shifts pharmaceutical manufacturer copay coupon policy
Registered Content

On January 1, 2020, the Centers for Medicare & Medicaid Services (CMS) released the proposed Notice of Benefit and Payment Parameters for 2021 (“2021 NBPP Proposed Rule”),...

Loading data